JourneyOne Ventures

Calling all Bostinos! Don't miss this VC Workshop on, "Health Meets Capital" on Saturday March 29th at Northeastern University. Check out the post below for full details ??

Interesting to see Kirsten Green (Managing Partner at Forerunner and All Raise founding member) making a significant $500M bet in consumer AI with Forerunner's Fund VII! ?? ?? ?? At JourneyOne Ventures, we're constantly evaluating the potential of AI across different sectors. If you're building in frontier health and wellness across software, biotech, consumer tech and digital health, this is your opportunity to pitch us: https://lnkd.in/etMTNTcz #AI #ConsumerTech #VentureCapital #FutureofAI

We’re proud to support the Contraline team as they pioneer advancements in male contraception with the ADAM? hydrogel. Read their peer-reviewed data in the Contraception journal—exciting times ahead! ??

The FDA's rejection of MDMA-assisted therapy in August 2024 was a huge let down for the 13M Americans suffering from PTSD. In this Financial Times opinion article, our founding partner Helene Servillon ???? demystifies psychedelic medicine and the emergence of frontier health and wellness remedies. ?? Key Takeaways from Helene’s POV: 1. The US is facing a mental health epidemic that adds up to $282bn a year in healthcare costs with 100M Americans on a daily psychoactive drug (adderall, sleeping pills and/or anti-depressants). 2. The most common prescription medicines for PTSD treatment are antidepressants (Zoloft and Paxil), which were approved by the FDA 25 years ago. They cause severe withdrawal symptoms and are only 20-30% effective with daily use commonly needed, whereas MDMA-assisted therapy is 87% with 3 treatment sessions. 3. As a firm, we aim to help people who suffer with acute depression and anxiety with holistic solutions that have long-lasting impact. We stand with Lykos Therapeutics and Multidisciplinary Association for Psychedelic Studies (MAPS) and the mission of the psychedelic medicine movement to create a paradigm shift in our healthcare system. Thank you to Elaine Moore and Kaitlyn Barclay for helping us shine light on this topic, and Sarah Stewart for her subject matter expertise! To read the full article: https://lnkd.in/eBqQ7jge Looking for a PDF version instead? Comment your email below and our fellow Shirley Wang will send it to you! #FrontierWellness #MentalHealth #PsychedelicMedicine #Innovation

At JourneyOne Ventures, we’re asked about our “investment syndicates” A LOT, and how they can help you get access to visionary startups with large (typical targets are 10-50x) return potential ?? So let’s kick it off with the basics… ?? What Are Syndicate Investments? Syndicate investments bring together groups of investors to pool their resources and invest in fast-growth startups on a deal-by-deal basis. Led by experienced "Syndicate Leads," these investment vehicles offer a unique opportunity to access high-quality deals that are not shopped around to just anybody, but top VC funds. ?? Key Benefits of Syndicate Investments: — Access to Exclusive Deals: Tap into a network of pre-vetted, high-potential startups led by Tier 1 VC firms. — Diversification: Spread your risk across multiple investments with smaller individual commitments. Eg $25K checks into 5 startups vs $250K check into one startup. — Expert Guidance: Benefit from seasoned VCs who are sourcing and doing diligence on the company with their expert network. — Optionality: Choose which deals to participate in based on your interests and risk tolerance (e.g. company stage and industry). ?? How It Works: Syndicate Investments in 5 Steps 1. Deal Sourcing & Diligence: Syndicate Lead identifies opportunities and conducts thorough vetting. 2. Deal Sharing: Comprehensive information about the deal is shared with syndicate members for consideration. 3. Investment Finalization: A Special Purpose Vehicle (SPV) is created; investors contribute funds for a pooled investment. 4. Waiting Period: Typically 7-10 years to exit, with regular updates and potential follow-on opportunities. 5. Potential Exit & Distribution: Upon a successful exit, your principal is returned first, then profits are distributed based on the SPV terms which is usually a 80/20 carry split. 80% of profits goes to you as the investor and 20% goes to the Syndicate Leads. Want to jump into more deals? Apply to our investment syndicate in the comments + follow us for Part 2!

It's onwards and upwards for our portfolio company Plant People (Hudson Davis-Ross, Gabe Kennedy)! ?? We're incredibly proud of their team's recent achievements and can't wait to continue supporting their growth ??

What does it mean to be in the health and wellness startup space today? … because it was surely the topic of last night’s Care to Gather dinner series themed “Aging and Longevity” ???? Thank you to Sheila Lirio Marcelo (Ohai.ai) for hosting a beautiful dinner and fireside chat with Ginna Baik (AOL) and Abby Levy (Primetime Partners)! Here are 3 powerful takeaways that stuck with our founding partner Helene Servillon ????: 1?? AI in healthcare faces challenges due to unstructured data, but it has potential to boost productivity in areas like patient intake forms. 2?? The aging Baby Boomer population of 68 million people—currently the largest demographic group taking up around 20% of the US population—is creating a significant demand for caregiving services. 3?? Despite many US politicians being Baby Boomers, there seems to be weak representation addressing the importance of caregiving issues on the hill. This is surprising because the care economy is a trillion dollar market and a core GDP and job driver.

The newest networking trend is here: introducing social saunas ?? …But what IS a social sauna? You can think of it as a communal space where people gather to relax and socialize in a heated environment (with cold plunges!). However, there’s been a growing trend in the tech industry where saunas are becoming a new networking hotspot, offering a healthier alternative to traditional social venues like bars. In fact, our JourneyOne Ventures founding partner Helene Servillon ???? is a big fan who’s working to help trailblaze the category. As an investor in frontier health & wellness, we’re always looking for wellness-centric ways to connect with founders, investors and our wider community. How are you starting your wellness work routine for 2025? Comment “SAUNA” and we’ll send you the pdf to The Wall Street Journal article. PS: Shoutout to Carta and Wishup for helping us throw our SF tech week wellness wind down event!

The women's U.S. health market is in for a BIG year — let’s break down a recent Forbes (https://hubs.la/Q031Pk530) to understand the latest trends and predictions: ?? What Trends Are Driving Women’s Health Sector? (1) Increasing recognition of women's unique healthcare needs (2) Biotech advancements addressing critical areas like ovarian health and cancer diagnostics (3) Push in telehealth to expand access to women's health services (4) AI-driven opportunities like innovation in diagnostics, care delivery, and personalized medicine (5) Focus on addressing maternal health disparities and improving pregnancy outcomes Here at JourneyOne Ventures, we're committed to shaping the future of frontier health and wellness. Are you building the next big thing in women's health tech? Let's chat! #WomensHealth #HealthTech #VCFunding #FrontierHealth

Overlooked, misunderstood and/or forgotten. These are the common attributes that we find amongst many frontier health and wellness companies. Tune into our podcast with Lucas J. Pols, GP of Pegasus Angel Accelerator to get the scoop on how we break down our investment thesis. ?? in comments